Ultrahuman Expands Health Capabilities with New On-Demand Heart Scan Feature for Ring Air and Ring Pro

Ultrahuman has significantly expanded the clinical health capabilities of its wearable ecosystem by introducing a new on-demand heart rhythm monitoring tool called Heart Scan. The feature builds directly upon the company’s existing atrial fibrillation, or AFib, detection infrastructure, offering users a more active way to monitor their cardiovascular wellness alongside the passive, automated tracking systems already built into the hardware.

The newly announced Heart Scan feature is powered by FibriCheck, a clinically validated health technology platform, and is designed for eligible users of both the Ultrahuman Ring Air and the newer Ring Pro. While the Ring Air gained automated atrial fibrillation detection support through a software update in July 2024, and the Ring Pro shipped with the capability natively following its launch in February, both wearables previously relied primarily on background, nighttime screenings. The introduction of Heart Scan changes this dynamic by empowering users to initiate a heart rhythm check manually, whenever they feel the need or wish to capture a targeted reading.

Operating as an integrated component of the broader AFib Detection PowerPlug within the Ultrahuman mobile application, Heart Scan allows users to trigger a rhythm assessment directly from their smartphone dashboard. Once initiated, the entire process takes precisely 60 seconds to complete. During this brief window, the user is required to remain still so that the optical and electrical sensors embedded within the Ultrahuman Ring can accurately read physiological signals from the finger. The raw data collected by the ring is then processed using advanced analytical algorithms developed by FibriCheck to evaluate the stability and regularity of the user’s pulse.

Upon the completion of the 60-second assessment, the analytical results are delivered directly to the user interface within the Ultrahuman application. Beyond simply displaying a basic status message, the system automatically generates a comprehensive FibriCheck PDF report. This detailed document is designed to provide actionable clinical insights that users can easily share with healthcare professionals. The report includes the raw pulse recording captured during the scan, a detailed tachogram illustrating the timing between heartbeats, and a Lorenz plot, which is a specialized scatter plot used by cardiologists to visualize the variability of intervals between consecutive heartbeats.

According to specifications provided by Ultrahuman, a completed Heart Scan can return one of several distinct diagnostic classifications based on the algorithmic evaluation. The results may indicate that the user’s heart rhythm is regular, point toward a possibly irregular rhythm, flag a potential case of atrial fibrillation, warn that the signal quality was too low to make a reliable determination, or conclude that the scan is inconclusive.

To ensure safe and responsible use of the wearable technology, Ultrahuman and FibriCheck emphasize important clinical limitations regarding what the tool can and cannot detect. The companies explicitly state that FibriCheck technology is not designed to detect heart attacks or acute ischemic conditions. Furthermore, they stress that receiving a regular result from a Heart Scan does not completely rule out the presence of an underlying heart rhythm condition, reinforcing that consumer-grade wearables serve as monitoring and screening aids rather than definitive diagnostic medical devices.

The rollout of the Heart Scan feature requires specific software updates across supported mobile platforms. To access the new functionality, users must ensure their Ultrahuman companion application is updated to version 4.3.0 for iOS devices, or version 3.2.0.0 for Android devices. The feature is rolling out across supported markets globally, including the United Kingdom, various European nations, the Middle East, and the Asia-Pacific region. Eligible owners of the Ultrahuman Ring Air and Ring Pro can access free scans directly from their customized application dashboard.

While the on-demand Heart Scan capability is being made accessible to eligible users from the dashboard, the continuous nighttime screening infrastructure operates through the dedicated AFib PowerPlug subscription model. In the United Kingdom, the nighttime screening service is priced at £4.90 per month, or £49 annually. For customers residing within the Eurozone, the pricing structure is set at €5.90 per month, or €49 annually.

For consumers who have not yet invested in the ecosystem and are looking to purchase one of the company’s flagship health-tracking smart rings, both the Ultrahuman Ring Air and the Ultrahuman Ring Pro remain available for purchase directly through the official online store at ultrahuman.com.